Home
Discover
Research
Finance
Strategy

Get 40% off Premium. Unlock the BEST of AlphaPilot.

Finance
FRLN

Overview Financials Analysis Smart Money

Freeline Therapeutics Holdings plc

FRLN · NASDAQ

Analyze with AI

Filings1

Total reported value$195.6K

Manager	Shares	Value	Change
Odey Asset Management Group Ltd	30.1K	$195.6K	0.0%

SymbolFRLN

Market Cap$28.3M

IPO Date2020-08-07

CEOMichael J. Parini

Employees152

SectorHealthcare

IndustryBiotechnology

CountryGB

ExchangeNASDAQ Global Select

Mega Fortune Company Limited

MGRT

$13.05

+143.93%

Processa Pharmaceuticals, Inc.

PCSA

$6.68

+122.30%

cbdMD, Inc.

YCBD

$2.27

+58.74%

Agape ATP Corporation

ATPC

$0.1408

+56.44%

IMAC Holdings, Inc.

BACK

$0.153

+50.00%

Peers

Allakos Inc.

ALLK · NASDAQ

$0.3291

+0.22%

Serina Therapeutics, Inc.

SER · NYSE

$2.94

+0.68%

AnPac Bio-Medical Science Co., Ltd.

ANPC · NASDAQ

$4.30

-3.15%

Liminal BioSciences Inc.

LMNL · NASDAQ

$8.50

+0.12%

Marinus Pharmaceuticals, Inc.

MRNS · NASDAQ

$0.55

+0.00%

Angion Biomedica Corp.

ANGN · NASDAQ

$1.00

+0.00%

LakeShore Biopharma Co., Ltd

LSB · NASDAQ

$0.627

+0.00%

Vincerx Pharma, Inc.

VINC · NASDAQ

$0.013

+0.00%

Elevation Oncology, Inc.

ELEV · NASDAQ

$0.365

-2.12%

MetaVia Inc.

MTVA · NASDAQ

$8.23

+1.11%

Home

Home
Research
Strategy
Signal
Discover

Education

Academy
Tutorial
Strategy
Agent
Finance

Resources

Pricing
Referral
Partners
FAQ

Other

Terms
Privacy

Disclaimer: Content on AlphaPilot is for informational purposes only and does not constitute financial or investment advice. Past performance, including backtested results, is not indicative of future outcomes. AlphaPilot makes no guarantees regarding accuracy or reliability; use at your own risk.